Home LiteratureArticle Details
PMID: 89387 Published · ppublish English Clinical Trial Journal Article

Cimetidine: interaction with oral anticoagulants in man.

Lancet (London, England) ·Vol. 2 ·No. 8138 ·1979-08-18 ·Pages 317-9

Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JR, Atwood JL, Willoughby JM

Abstract

In 6 patients anticoagulated with warfarin, nicoumalone, or phenindione the addition of cimetidine prolonged the prothrombin-time (PT) by a mean of 12.6 s (range 5--23 s). In 7 volunteers taking daily subtherapeutic doses of warfarin the addition of cimetidine increased the PT from 19.4 to 22.9 s and the plasma-warfarin concentration from 0.96 to 1.76 microgram/ml. Cimetidine reduced the single-dose clearance of warfarin and antipyrine. The basis of the interaction between cimetidine and oral anticoagulants is probably inhibition of drug metabolism. Care should be exercised in concomitant therapy.

MeSH Terms
Acenocoumarol/administration & dosage,metabolism Administration, Oral Adult Aged Antipyrine/metabolism Biological Availability Cimetidine/pharmacology,therapeutic use Clinical Trials as Topic Drug Synergism Female Guanidines/pharmacology Half-Life Humans Male Middle Aged Phenindione/administration & dosage,metabolism Prothrombin Time Warfarin/administration & dosage,metabolism
Chemicals
Guanidines Phenindione Warfarin Cimetidine Acenocoumarol Antipyrine
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Serlin M J
Sibeon R G
Mossman S
Breckenridge A M
Williams J R
Atwood J L
Willoughby J M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1979-08-18
Pages
317-9
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com